BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9625858)

  • 1. nm23 protein expression in renal cell tumors: the role of the cell type.
    Ayhan A; Usubütün A; Ozen H; Yasui W; Tahara E
    Oncol Rep; 1998; 5(4):979-83. PubMed ID: 9625858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
    Kuo JY; Chang KM; Chen KK; Chang LS
    Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of nm23-H4 RNA in colorectal and renal tumours.
    Hayer J; Engel M; Seifert M; Seitz G; Welter C
    Anticancer Res; 2001; 21(4A):2821-5. PubMed ID: 11724361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of nm23 expression as a prognostic parameter in renal cell carcinoma.
    Park DS; Cho NH; Lee YT; Park C; Lee JM
    J Korean Med Sci; 1995 Aug; 10(4):258-62. PubMed ID: 8593205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of nm23 expression in renal cell carcinoma.
    Ljungberg B; Osterdahl B; Mehle C
    Urol Res; 1999 Apr; 27(2):103-7. PubMed ID: 10424391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NM23-H1 and NM23-H2 gene expression in human renal tumors.
    Theisinger B; Engel M; Seifert M; Seitz G; Welter C
    Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
    J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma.
    Filiz G; Adim S; Aytac B; Akar E; Vuruskan H
    J Int Med Res; 2010; 38(2):620-4. PubMed ID: 20515575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
    Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
    Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma.
    Hiasa Y; Konishi N; Tao M; Matsuda H; Tsumatani K; Nakamura Y; Kitahori Y; Ozono S; Hirao Y; Okajima E
    Oncology; 1996; 53(1):79-87. PubMed ID: 8570138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
    Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
    Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
    Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
    Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
    Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
    J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
    Yoo CH; Noh SH; Kim H; Lee HY; Min JS
    J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression.
    Kawakubo Y; Sato Y; Koh T; Kono H; Kameya T
    Lung Cancer; 1997 May; 17(1):103-13. PubMed ID: 9194030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
    Kaya H; Hücümenoğlu S; Bozkurt SU; Ekicioğlu G; Kotiloğlu E
    Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.